Status:
COMPLETED
Borderline Resectable or Resectable or Advanced Pancreatic Adenocarcinoma
Lead Sponsor:
Hellenic Society of Medical Oncology
Conditions:
Pancreatic Adenocarcinoma
Eligibility:
All Genders
18+ years
Brief Summary
Observational study of the Clinical Practice in patients with Borderline resectable or resectable or advanced pancreatic adenocarcinoma.
Eligibility Criteria
Inclusion
- Patients Age 18 or older with histologically confirmed ductal pancreatic adenocarcinoma as a primary tumor
- Patients with ductal pancreatic adenocarcinoma (Borderline resectable or resectable or advanced)
- Patients that are alive and under treatment or follow up
- Signed informed consent (ICF)
Exclusion
- Presence of other primary tumors
- Pancreatic adenocarcinoma due to metastasis from other primary tumor(s)
- Neuroendocrine or other pancreatic carcinoma other than ductal adenocarcinoma
- Patients who refuse to provide informed consent
Key Trial Info
Start Date :
February 11 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 11 2018
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03266757
Start Date
February 11 2016
End Date
February 11 2018
Last Update
April 5 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.